These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8237208)

  • 1. Efficacy of various non-oily adjuvants in immunization against the Aujeszky's disease (pseudorabies) virus.
    Puentes E; Cancio E; Eiras A; Nores MV; Aguilera A; Regueiro BJ; Seoane R
    Zentralbl Veterinarmed B; 1993 Jul; 40(5):353-65. PubMed ID: 8237208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the protective efficacy of Aujeszky's disease (pseudorabies) virus glycoproteins obtained from different sources.
    Puentes E; Eiras A; Cancio E; Nores MV; Aguilera A; Seoane R; Regueiro BJ
    Vet Microbiol; 1993 May; 35(1-2):45-59. PubMed ID: 8395745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formaldehyde-fixed cells infected with pseudorabies virus conferred resistance against Aujeszky's disease.
    Tanaka S; Imamura T; Matsui H; Sakaguchi M; Matsuo K; Yamamoto M
    J Vet Med Sci; 1994 Dec; 56(6):1177-9. PubMed ID: 7696414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of Aujeszky's disease.
    Kit S; Sheppard M; Kit M
    Vet Rec; 1986 Mar; 118(11):310. PubMed ID: 3010537
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigens involved in vaccination of swine against Aujeszky's disease (pseudorabies) virus.
    Eiras A; Puentes E; Seoane R; Cancio E; Nores MV; Regueiro BJ
    Zentralbl Veterinarmed B; 1992 Sep; 39(7):526-36. PubMed ID: 1333691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iscom of viral envelope proteins protects against Aujeszky's disease.
    Morein B; Belák S; Soós T; Rusvai M; McGwire BS; Bognár K
    Vet Microbiol; 1989 Jun; 20(2):143-54. PubMed ID: 2549682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of antigenic forms and adjuvants on protection against a lethal infection of Aujeszky's disease virus.
    Katayama S; Oda K; Ohgitani T
    Vaccine; 2000 Aug; 19(1):54-8. PubMed ID: 10924786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.
    Ishii H; Kobayashi Y; Kuroki M; Kodama Y
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1411-4. PubMed ID: 2838579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells.
    Marchioli CC; Yancey RJ; Petrovskis EA; Timmins JG; Post LE
    J Virol; 1987 Dec; 61(12):3977-82. PubMed ID: 2824827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines.
    Nauwynck HJ; Zonnekeyn V; Pensaert MB
    Zentralbl Veterinarmed B; 1997 Dec; 44(10):609-15. PubMed ID: 9467303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mice against Aujeszky's disease virus infection by intranasal vaccination with inactivated virus.
    Takada A; Shimizu Y; Kida H
    J Vet Med Sci; 1994 Aug; 56(4):633-7. PubMed ID: 7999882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
    Gerdts V; Jöns A; Mettenleiter TC
    Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky's disease virus.
    Visser N
    Vet Microbiol; 1997 Apr; 55(1-4):61-74. PubMed ID: 9220597
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental studies in weaned pigs with three vaccines against Aujeszky's disease.
    McFerran JB; Dow C; McCracken RM
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):327-34. PubMed ID: 228904
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of immune responses to glycoprotein gD of Aujeszky's disease virus with DNA immunization.
    Hwang DY; Lee JB; Kim TJ; Song JY; Hyun BH; Song CS; Park SY
    J Vet Med Sci; 2001 Jun; 63(6):659-62. PubMed ID: 11459012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of pigs against Aujeszky's disease by DNA vaccination.
    Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination of piglets of different ages with inactivated Aujeszky's disease vaccine].
    Jakubik J; Wittmann G
    Berl Munch Tierarztl Wochenschr; 1979 Sep; 92(17):343-5. PubMed ID: 231429
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination of 'non-swine' against Aujeszky's disease].
    Akkermans JP
    Tijdschr Diergeneeskd; 1980 Dec; 105(24):1084-5. PubMed ID: 6255630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.